Fiasp is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk. The primary component is Insulin Aspart.
Product ID | 0169-3204_0d8112c7-3e31-4272-911f-06e803633178 |
NDC | 0169-3204 |
Product Type | Human Prescription Drug |
Proprietary Name | Fiasp |
Generic Name | Insulin Aspart Injection |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2017-10-20 |
Marketing Category | BLA / NDA |
Application Number | BLA208751 |
Labeler Name | Novo Nordisk |
Substance Name | INSULIN ASPART |
Active Ingredient Strength | 100 [iU]/mL |
Pharm Classes | Insulin [CS],Insulin Analog [EPC] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 2017-10-20 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA208751 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2017-10-20 |
Marketing Category | NDA |
Application Number | NDA208751 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2017-10-20 |
Marketing Category | NDA |
Application Number | NDA208751 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-10-30 |
Ingredient | Strength |
---|---|
INSULIN ASPART | 100 [iU]/mL |
SPL SET ID: | 834e7efc-393f-4c55-9125-628562a8a5cf |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
0169-3201 | Fiasp | insulin aspart injection |
0169-3204 | Fiasp | insulin aspart injection |
0169-3205 | Fiasp | insulin aspart injection |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
FIASP 79162960 4966787 Live/Registered |
Novo Nordisk A/S 2015-02-09 |
FIASP 79140450 4541341 Live/Registered |
Novo Nordisk A/S 2013-10-28 |